Specialties
- Men’s health
- Stone disease
- Prostate cancer
- Testicular cancer
- Fertility and sterility
- Hematuria
- Vasectomy
- Endoscopic kidney stone treatment
- Urolift
- Benign prostate enlargement treatment
- Endoscopic bladder cancer treatment
- Brachytherapy
- Testicular cancer
- Elevated PSA
- Benign prostatic hyperplasia
- Kidney stones
- Men’s sexual dysfunction
- Hypogonadism
- Male fertility and sterility
- Voiding dysfunction
Call for patient appointments: 314-362-8200
Meet Dr. Glaser
Dr. Jeffrey Glaser is a urologic surgeon specializing in men’s health.
He has expertise in the treatment of urologic cancers, voiding dysfunction, and fertility.
Dr. Glaser earned his medical degree from University of Missouri – Columbia School of Medicine. He completed urologic residency training at University of Illinois and Michael Reese Hospital.
Degrees
Medical Degree
University of Missouri – Columbia School of Medicine, Columbia, MO
1987
Residency
Urology Residency
University of Illinois/Michael Reese Hospital, Chicago, Il
1992
Research interests
Clinical outcomes
Prostate cancer
Active surveillance
Squamous cell carcinoma
Locations
Barnes-Jewish St. Peters Hospital
70 Jungermann Circle
Medical Office Building 2
St. Peters, MO 63376
Suite 402
Fax: 888-425-8245
Appointments: 314-362-8200
Hospital affiliations
Barnes-Jewish St. Peters Hospital
Progress West Hospital
Board certifications
- American Board of Urology
Dr. Glaser in the news
- Kimberly Berni, MD, and Jeffrey Glaser, MD, Join Washington University Urology
- Department of Surgery New Faculty: July 2022
- Urologic Surgery
Professional Memberships
American Urological Association
Fellow, American College of Surgeons
American Association of Clinical Urologists
South Central Section of the American Urological Association
Missouri State Medical Society
Saint Charles/Lincoln Society Medical Society
Activities, Awards and Honors
Board member, Current President, Missouri State Board of Registration for the Healing Arts
CPT Advisor to the AMA, Past President of the St. Charles-Lincoln County Medical Society
Clinical Trials
Clinical Outcomes in Men with Prostate Cancer Who Have Selected Active Surveillance Using Clinical Cell-Cycle Risk Score (paper submitted to Journal of Urology, Jan. 16, 2019)